KRISTIN PULLINS: Open Payments
NPI 1811582729 · KEOKUK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 22 payments from 8 companies in 2025. Trend: 2023 $77 · 2024 $545 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $159 |
| Novo Nordisk Inc | 4 | $69 |
| Lilly USA, LLC | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Amgen Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, MOUNJARO, AIRSUPRA, Ozempic, Wegovy, Rybelsus, REXULTI, VOQUEZNA.
Industry payments across IA — which companies pay providers there.
